» Articles » PMID: 19859070

Possible Renoprotection by Vitamin D in Chronic Renal Disease: Beyond Mineral Metabolism

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2009 Oct 28
PMID 19859070
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D is typically viewed as a key player in the regulation of calcium and phosphate levels and the control of bone metabolism; however, growing evidence suggests that vitamin D deficiency may also have an important role in the progressive loss of renal function. Vitamin D deficiency is particularly frequent in patients with chronic kidney disease, in whom it is associated with increased mortality. Studies indicate that treatment with vitamin D analogues reduces proteinuria, suppresses the renin-angiotensin-aldosterone system (RAAS), and exerts anti-inflammatory and immunomodulatory effects. These pleiotropic effects render vitamin D a potentially interesting treatment modality for renoprotection in patients with chronic kidney disease. Whether vitamin D has clinically relevant renoprotective effects in addition to RAAS blockade is currently under investigation.

Citing Articles

Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation.

Alfieri C, Molinari P, Vettoretti S, Fusaro M, Bover J, Cianciolo G J Nephrol. 2024; 37(6):1477-1485.

PMID: 39223353 DOI: 10.1007/s40620-024-02055-x.


Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism.

Merante D, Schou H, Morin I, Manu M, Ashfaq A, Bishop C Nephron. 2024; 148(10):657-666.

PMID: 38657576 PMC: 11460832. DOI: 10.1159/000538818.


The impact of vitamin D on the etiopathogenesis and the progression of type 1 and type 2 diabetes in children and adults.

Li C, Fu J, Ye Y, Li J, He Y, Fang T Front Endocrinol (Lausanne). 2024; 15:1360525.

PMID: 38650715 PMC: 11033370. DOI: 10.3389/fendo.2024.1360525.


Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease.

Houske E, Glimm M, Bergstrom A, Slipher S, Welhaven H, Greenwood M Am J Physiol Renal Physiol. 2023; 324(6):F590-F602.

PMID: 37141147 PMC: 10281782. DOI: 10.1152/ajprenal.00301.2022.


The efficacy and safety of self-administered acupressure on respiratory tract infection in chronic kidney disease: a randomized controlled trial.

Liu M, Sheng H, Huang J, Xuan M, Ouyang W, Zhang Y Ann Transl Med. 2022; 10(12):688.

PMID: 35845502 PMC: 9279760. DOI: 10.21037/atm-22-2376.


References
1.
Norman A . Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006; 147(12):5542-8. DOI: 10.1210/en.2006-0946. View

2.
Schwarz U, Amann K, Orth S, Simonaviciene A, Wessels S, Ritz E . Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 1998; 53(6):1696-705. DOI: 10.1046/j.1523-1755.1998.00951.x. View

3.
Hamming I, Navis G, Kocks M, van Goor H . ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J Pathol. 2006; 209(1):129-39. DOI: 10.1002/path.1956. View

4.
de Boer I, Ioannou G, Kestenbaum B, Brunzell J, Weiss N . 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007; 50(1):69-77. DOI: 10.1053/j.ajkd.2007.04.015. View

5.
Adams J, Hewison M . Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008; 4(2):80-90. PMC: 2678245. DOI: 10.1038/ncpendmet0716. View